Fresenius Medical Care AG KGaA ROA 2012-2025 | FMS
Current and historical return on assets (ROA) values for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Fresenius Medical Care AG KGaA ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $0.81B | $36.10B | 2.26% |
| 2025-06-30 | $0.72B | $35.52B | 2.02% |
| 2025-03-31 | $0.66B | $34.49B | 1.85% |
| 2024-12-31 | $0.58B | $36.32B | 1.59% |
| 2024-09-30 | $0.72B | $35.75B | 1.96% |
| 2024-06-30 | $0.57B | $36.50B | 1.54% |
| 2024-03-31 | $0.53B | $37.28B | 1.39% |
| 2023-12-31 | $0.54B | $36.72B | 1.43% |
| 2023-09-30 | $0.48B | $38.79B | 1.27% |
| 2023-06-30 | $0.62B | $38.12B | 1.63% |
| 2023-03-31 | $0.63B | $38.11B | 1.64% |
| 2022-12-31 | $0.71B | $37.67B | 1.85% |
| 2022-09-30 | $0.83B | $38.68B | 2.11% |
| 2022-06-30 | $0.92B | $38.39B | 2.32% |
| 2022-03-31 | $1.02B | $38.97B | 2.57% |
| 2021-12-31 | $1.15B | $40.66B | 2.86% |
| 2021-09-30 | $1.10B | $39.89B | 2.83% |
| 2021-06-30 | $1.19B | $39.75B | 3.09% |
| 2021-03-31 | $1.32B | $39.98B | 3.46% |
| 2020-12-31 | $1.33B | $36.20B | 3.54% |
| 2020-09-30 | $1.49B | $38.63B | 3.96% |
| 2020-06-30 | $1.45B | $37.65B | 3.89% |
| 2020-03-31 | $1.35B | $37.59B | 3.66% |
| 2019-12-31 | $1.34B | $36.89B | 3.67% |
| 2019-09-30 | $1.45B | $36.88B | 4.11% |
| 2019-06-30 | $1.41B | $35.92B | 4.22% |
| 2019-03-31 | $2.31B | $36.75B | 7.24% |
| 2018-12-31 | $2.34B | $30.99B | 7.78% |
| 2018-09-30 | $2.32B | $29.75B | 7.96% |
| 2018-06-30 | $2.35B | $29.87B | 8.15% |
| 2018-03-31 | $1.46B | $29.69B | 5.19% |
| 2017-12-31 | $1.45B | $27.16B | 5.24% |
| 2017-09-30 | $1.38B | $28.50B | 5.00% |
| 2017-06-30 | $1.35B | $27.19B | 4.97% |
| 2017-03-31 | $1.34B | $27.47B | 4.99% |
| 2016-12-31 | $1.24B | $26.93B | 4.68% |
| 2016-09-30 | $1.17B | $26.66B | 4.48% |
| 2016-06-30 | $1.10B | $26.55B | 4.26% |
| 2016-03-31 | $1.05B | $26.07B | 4.10% |
| 2015-12-31 | $1.03B | $25.37B | 4.07% |
| 2015-09-30 | $1.05B | $25.41B | 4.14% |
| 2015-06-30 | $1.06B | $25.41B | 4.22% |
| 2015-03-31 | $1.05B | $25.11B | 4.25% |
| 2014-12-31 | $1.05B | $25.38B | 4.30% |
| 2014-09-30 | $1.06B | $24.25B | 4.46% |
| 2014-06-30 | $1.06B | $24.15B | 4.55% |
| 2014-03-31 | $1.09B | $23.42B | 4.77% |
| 2013-12-31 | $1.11B | $23.12B | 4.93% |
| 2013-09-30 | $1.02B | $22.54B | 4.56% |
| 2013-06-30 | $1.02B | $22.33B | 4.58% |
| 2013-03-31 | $1.04B | $22.14B | 4.73% |
| 2012-12-31 | $1.19B | $22.33B | 5.40% |
| 2012-09-30 | $1.24B | $21.86B | 5.82% |
| 2012-06-30 | $1.25B | $21.74B | 6.10% |
| 2012-03-31 | $1.22B | $21.99B | 6.16% |
| 2011-12-31 | $1.07B | $19.53B | 5.69% |
| 2011-09-30 | $1.03B | $18.63B | 5.66% |
| 2011-06-30 | $1.00B | $19.05B | 5.64% |
| 2011-03-31 | $0.99B | $18.11B | 5.82% |
| 2010-12-31 | $0.98B | $17.10B | 5.96% |
| 2010-09-30 | $0.95B | $16.70B | 5.93% |
| 2010-06-30 | $0.93B | $16.00B | 5.87% |
| 2010-03-31 | $0.90B | $15.87B | 5.76% |
| 2009-12-31 | $0.89B | $15.82B | 5.77% |
| 2009-09-30 | $0.86B | $15.70B | 5.64% |
| 2009-06-30 | $0.84B | $15.34B | 5.60% |
| 2009-03-31 | $0.83B | $14.87B | 5.57% |
| 2008-12-31 | $0.82B | $14.92B | 5.52% |
| 2008-09-30 | $0.80B | $14.78B | 5.47% |
| 2008-06-30 | $0.78B | $14.91B | 5.40% |
| 2008-03-31 | $0.74B | $14.59B | 5.30% |
| 2007-12-31 | $0.72B | $14.17B | 5.24% |
| 2007-09-30 | $0.67B | $13.76B | 5.01% |
| 2007-06-30 | $0.63B | $13.55B | 4.80% |
| 2007-03-31 | $0.58B | $13.25B | 4.50% |
| 2006-12-31 | $0.54B | $13.05B | 4.16% |
| 2006-09-30 | $0.50B | $12.67B | 4.31% |
| 2006-06-30 | $0.48B | $12.64B | 4.57% |
| 2006-03-31 | $0.46B | $13.14B | 5.03% |
| 2005-12-31 | $0.46B | $7.98B | 5.75% |
| 2005-09-30 | $0.45B | $7.97B | 5.65% |
| 2005-06-30 | $0.43B | $7.81B | 5.52% |
| 2005-03-31 | $0.42B | $7.89B | 5.35% |
| 2004-12-31 | $0.40B | $7.96B | 5.18% |
| 2004-09-30 | $0.47B | $7.72B | 6.16% |
| 2004-06-30 | $0.42B | $7.67B | 6.02% |
| 2004-03-31 | $0.38B | $7.71B | 5.85% |
| 2003-12-31 | $0.33B | $7.50B | 5.70% |
| 2003-09-30 | $0.24B | $5.30B | 4.55% |
| 2003-06-30 | $0.22B | $5.24B | 4.25% |
| 2003-03-31 | $0.20B | $5.18B | 3.92% |
| 2002-12-31 | $0.19B | $5.01B | 3.86% |
| 2002-09-30 | $-0.01B | $4.99B | -0.12% |
| 2002-06-30 | $0.02B | $5.02B | 0.44% |
| 2002-03-31 | $0.02B | $4.99B | 0.37% |
| 2001-12-31 | $0.03B | $5.00B | 0.69% |
| 2001-09-30 | $0.21B | $4.95B | 4.48% |
| 2001-06-30 | $0.20B | $4.57B | 4.42% |
| 2001-03-31 | $0.20B | $4.60B | 4.28% |
| 2000-12-31 | $0.19B | $4.55B | 4.06% |
| 2000-09-30 | $0.15B | $4.64B | 3.22% |
| 2000-06-30 | $-0.28B | $4.64B | -5.88% |
| 2000-03-31 | $-0.26B | $4.62B | -5.53% |
| 1999-12-31 | $-0.27B | $4.65B | -5.70% |
| 1999-09-30 | $-0.25B | $4.80B | -5.43% |
| 1999-06-30 | $0.15B | $4.61B | 3.29% |
| 1999-03-31 | $0.04B | $4.60B | 0.93% |
| 1998-12-31 | $0.03B | $4.61B | 0.66% |
| 1998-09-30 | $-0.07B | $4.63B | -1.45% |
| 1998-06-30 | $-0.12B | $4.73B | -2.55% |
| 1998-03-31 | $-0.02B | $4.87B | -0.49% |
| 1997-12-31 | $-0.02B | $5.01B | -0.51% |
| 1997-09-30 | $2.50B | $4.20B | 53.75% |
| 1997-06-30 | $2.53B | $4.82B | 54.83% |
| 1997-03-31 | $2.84B | $4.66B | 56.85% |
| 1996-12-31 | $2.83B | $4.95B | 51.97% |
| 1996-09-30 | $-0.10B | $4.05B | -1.78% |
| 1996-06-30 | $-0.10B | $6.31B | -1.58% |
| 1996-03-31 | $-0.36B | $6.49B | -5.66% |
| 1995-12-31 | $-0.33B | $6.30B | -5.21% |
| 1995-09-30 | $0.25B | $6.23B | 4.05% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $20.627B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $231.230B | 27.48 |
| Intuitive Surgical (ISRG) | United States | $205.316B | 80.33 |
| IDEXX Laboratories (IDXX) | United States | $57.873B | 57.47 |
| Edwards Lifesciences (EW) | United States | $48.171B | 32.30 |
| IQVIA Holdings (IQV) | United States | $41.018B | 22.87 |
| Alcon (ALC) | Switzerland | $39.884B | 26.95 |
| Mettler-Toledo (MTD) | United States | $30.479B | 35.66 |
| DexCom (DXCM) | United States | $27.683B | 38.16 |
| STERIS (STE) | Ireland | $25.594B | 26.42 |
| Waters (WAT) | United States | $23.443B | 31.00 |
| Coloplast (CLPBY) | Denmark | $20.255B | 34.57 |
| Hologic (HOLX) | United States | $16.687B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.899B | 0.00 |
| Penumbra (PEN) | United States | $12.511B | 88.01 |
| Globus Medical (GMED) | United States | $12.276B | 25.76 |
| Masimo (MASI) | United States | $7.103B | 22.76 |
| Sysmex ADR (SSMXY) | Japan | $6.421B | 20.40 |
| Glaukos (GKOS) | United States | $6.370B | 0.00 |
| Teleflex (TFX) | United States | $4.798B | 7.65 |
| TransMedics (TMDX) | United States | $4.602B | 54.52 |
| Veracyte (VCYT) | United States | $3.435B | 39.14 |
| LivaNova (LIVN) | United Kingdom | $3.406B | 18.40 |
| Integer Holdings (ITGR) | United States | $2.928B | 13.74 |
| Alphatec Holdings (ATEC) | United States | $2.613B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.407B | 22.52 |
| Artivion (AORT) | United States | $2.032B | 93.24 |
| UFP Technologies (UFPT) | United States | $1.997B | 26.36 |
| Nihon Kohden (NHNKY) | Japan | $1.986B | 17.34 |
| PROCEPT BioRobotics (PRCT) | United States | $1.751B | 0.00 |
| AxoGen (AXGN) | United States | $1.455B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.448B | 0.00 |
| IRadimed (IRMD) | United States | $1.245B | 59.33 |
| Integra LifeSciences Holdings (IART) | United States | $1.024B | 5.55 |
| OPKO Health (OPK) | United States | $1.021B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.987B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.777B | 0.00 |
| SiBone (SIBN) | United States | $0.775B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.667B | 38.79 |
| Pacific Biosciences Of California (PACB) | United States | $0.607B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.604B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.601B | 0.00 |
| NeuroPace (NPCE) | United States | $0.563B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.556B | 11.08 |
| OrthoPediatrics (KIDS) | United States | $0.504B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.464B | 12.80 |
| ClearPoint Neuro (CLPT) | United States | $0.445B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.420B | 0.00 |
| RxSight (RXST) | United States | $0.415B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.392B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.363B | 60.53 |
| Semler Scientific (SMLR) | United States | $0.344B | 2.57 |
| Spectral Diagnostics (EDTXF) | Canada | $0.299B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.196B | 0.00 |
| CVRx (CVRX) | United States | $0.192B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.187B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.178B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.150B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.143B | 0.00 |
| LENSAR (LNSR) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.136B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| Solana (HSDT) | United States | $0.133B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Accuray (ARAY) | United States | $0.099B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.084B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.065B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.021B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |